Alzheimer's and vascular disease classification using regional texture biomarkers in FLAIR MRI
- PMID: 36989851
- PMCID: PMC10074987
- DOI: 10.1016/j.nicl.2023.103385
Alzheimer's and vascular disease classification using regional texture biomarkers in FLAIR MRI
Abstract
Interactions between subcortical vascular disease and dementia due to Alzheimer's disease (AD) are unclear, and clinical overlap between the diseases makes diagnosis challenging. Existing studies have shown regional microstructural changes specific to each disease, and that textures in fluid-attenuated inversion recovery (FLAIR) MRI images may characterize abnormalities in tissue microstructure. This work aims to investigate regional FLAIR biomarkers that can differentiate dementia cohorts with and without subcortical vascular disease. FLAIR and diffusion MRI (dMRI) volumes were obtained in 65 mild cognitive impairment (MCI), 21 AD, 44 subcortical vascular MCI (scVMCI), 22 Mixed etiology, and 48 healthy elderly patients. FLAIR texture and intensity biomarkers were extracted from the normal appearing brain matter (NABM), WML penumbra, blood supply territory (BST), and white matter tract regions of each patient. All FLAIR biomarkers were correlated to dMRI metrics in each region and global WML load, and biomarker means between groups were compared using ANOVA. Binary classifications were performed using Random Forest classifiers to investigate the predictive nature of the regional biomarkers, and SHAP feature analysis was performed to further investigate optimal regions of interest for differentiating disease groups. The regional FLAIR biomarkers were strongly correlated to MD, while all biomarker regions but white matter tracts were strongly correlated to WML burden. Classification between Mixed disease and healthy, AD, and scVMCI patients yielded accuracies of 97%, 81%, and 72% respectively using WM tract biomarkers. Classification between scVMCI and healthy, MCI, and AD patients yielded accuracies of 89%, 84%, and 79% respectively using penumbra biomarkers. Only the classification between AD and healthy patients had optimal results using NABM biomarkers. This work presents novel regional FLAIR biomarkers that may quantify white matter degeneration related to subcortical vascular disease, and which indicate that investigating degeneration in specific regions may be more important than assessing global WML burden in vascular disease groups.
Keywords: Alzheimer’s disease; FLAIR; Neurodegeneration; Regional biomarkers; Subcortical vascular disease; Texture analysis.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
FLAIR MRI biomarkers of the normal appearing brain matter are related to cognition.Neuroimage Clin. 2022;34:102955. doi: 10.1016/j.nicl.2022.102955. Epub 2022 Feb 8. Neuroimage Clin. 2022. PMID: 35180579 Free PMC article.
-
Detecting conversion from mild cognitive impairment to Alzheimer's disease using FLAIR MRI biomarkers.Neuroimage Clin. 2023;40:103533. doi: 10.1016/j.nicl.2023.103533. Epub 2023 Nov 3. Neuroimage Clin. 2023. PMID: 37952286 Free PMC article.
-
Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.Alzheimers Res Ther. 2017 Aug 17;9(1):63. doi: 10.1186/s13195-017-0292-4. Alzheimers Res Ther. 2017. PMID: 28818116 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.J Alzheimers Dis. 2018;63(2):515-527. doi: 10.3233/JAD-170573. J Alzheimers Dis. 2018. PMID: 29630548 Review.
Cited by
-
Altered brain texture features in end-stage renal disease patients: a voxel-based 3D brain texture analysis study.Front Neurosci. 2024 Oct 11;18:1471286. doi: 10.3389/fnins.2024.1471286. eCollection 2024. Front Neurosci. 2024. PMID: 39464423 Free PMC article.
-
Synthesis of diffusion-weighted MRI scalar maps from FLAIR volumes using generative adversarial networks.Front Neuroinform. 2023 Aug 2;17:1197330. doi: 10.3389/fninf.2023.1197330. eCollection 2023. Front Neuroinform. 2023. PMID: 37603783 Free PMC article.
-
Brain Maturation Patterns on Normalized FLAIR MR Imaging in Children and Adolescents.AJNR Am J Neuroradiol. 2023 Sep;44(9):1077-1083. doi: 10.3174/ajnr.A7966. Epub 2023 Aug 17. AJNR Am J Neuroradiol. 2023. PMID: 37591770 Free PMC article.
-
In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases.Neurol Int. 2023 Aug 10;15(3):967-979. doi: 10.3390/neurolint15030062. Neurol Int. 2023. PMID: 37606395 Free PMC article. Review.
-
Stratifying vascular disease patients into homogeneous subgroups using machine learning and FLAIR MRI biomarkers.Npj Imaging. 2024;2(1):56. doi: 10.1038/s44303-024-00063-x. Epub 2024 Dec 31. Npj Imaging. 2024. PMID: 39749287 Free PMC article.
References
-
- Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H. The diagnosis of mild cognitive impairment due to alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimer’s Dementia: The Journal of the Alzheimer’s Association. 2011;7:270–279. - PMC - PubMed
-
- V. M. Anderson, J. M. Schott, J. W. Bartlett, K. K. Leung, D. H. Miller, and N. C. Fox, “Gray matter atrophy rate as a marker of disease progression in AD,” Neurobiology of Aging, vol. 33, no. 7, pp. 1194–1202, Jul. 2012. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657171/. - PMC - PubMed
-
- Bahsoun M.-A., Khan M.U., Mitha S., Ghazvanchahi A., Khosravani H., Jabehdar Maralani P., Tardif J.-C., Moody A.R., Tyrrell P.N., Khademi A. FLAIR MRI biomarkers of the normal appearing brain matterare related to cognition. NeuroImage: Clinical. 2022;34 https://www.sciencedirect.com/science/article/pii/S2213158222000201 [Online]. Available: - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical